Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCo-Diagnostics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.31 | -$0.23 | -$0.27 |
| Q2 2025 | 1 | -$0.29 | -$0.21 | -$0.25 |
| Q3 2025 | 1 | -$0.22 | -$0.16 | -$0.19 |
| Q4 2025 | 1 | -$0.14 | -$0.10 | -$0.12 |
| Q1 2026 | 1 | -$0.15 | -$0.10 | -$0.13 |
| Q2 2026 | 1 | -$0.12 | -$0.08 | -$0.10 |
| Q3 2026 | 1 | -$0.11 | -$0.08 | -$0.10 |
| Q4 2026 | 1 | -$0.10 | -$0.08 | -$0.09 |
| Q1 2027 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q2 2027 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q3 2027 | 1 | -$0.04 | -$0.03 | -$0.03 |
| Q4 2027 | 1 | -$0.05 | -$0.03 | -$0.04 |
| Q1 2028 | 1 | $0.13 | $0.18 | $0.16 |
| Q2 2028 | 1 | $0.14 | $0.19 | $0.16 |
| Q3 2028 | 1 | $0.13 | $0.19 | $0.16 |
| Q4 2028 | 1 | $0.13 | $0.19 | $0.16 |
Co-Diagnostics, Inc. Earnings Date And Information
Co-Diagnostics, Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.03. The company had revenue of 145.38 K for the quarter and had revenue of 3.92 M for the year. Co-Diagnostics, Inc. has generated $-1 earnings per share over the last year ($-1.24 diluted earnings per share) and currently has a price-to-earnings ratio of -0.41. Co-Diagnostics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 13th, 2025 based on prior year's report dates.
Co-Diagnostics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | -$0.19 | -$0.16 | 0.03 | $300.00 K | $145.38 K |
| 08/14/2025 | Q2 2025 | -$0.25 | -$0.23 | 0.02 | $300.00 K | $162.91 K |
| 05/08/2025 | Q1 2025 | -$0.33 | -$0.24 | 0.09 | N/A | $50.28 K |
| 03/27/2025 | Q4 2024 | -$0.34 | -$0.33 | 0.01 | N/A | $149.33 K |
| 11/07/2024 | Q3 2024 | -$0.33 | -$0.32 | 0.01 | $375.00 K | $641.14 K |
| 08/08/2024 | Q2 2024 | -$0.34 | -$0.25 | 0.09 | $400.00 K | $2.66 M |
| 05/09/2024 | Q1 2024 | -$0.21 | -$0.31 | -0.1 | N/A | $252.75 K |
| 03/14/2024 | Q4 2023 | -$0.20 | -$0.47 | -0.27 | N/A | $3.56 M |
| 11/09/2023 | Q3 2023 | -$0.29 | -$0.20 | 0.09 | $200.00 K | $2.46 M |
| 08/10/2023 | Q2 2023 | -$0.24 | -$0.31 | -0.07 | $500.00 K | $197.81 K |
| 05/11/2023 | Q1 2023 | -$0.23 | -$0.20 | 0.03 | $1.10 M | $601.96 K |
| 03/16/2023 | Q4 2022 | -$0.15 | -$0.71 | -0.56 | $5.50 M | $1.40 M |
| 11/10/2022 | Q3 2022 | -$0.06 | -$0.04 | 0.02 | $7.48 M | $5.09 M |
| 08/11/2022 | Q2 2022 | $0.15 | -$0.08 | -0.23 | $15.34 M | $5.02 M |
| 05/12/2022 | Q1 2022 | $0.18 | $0.35 | 0.17 | $21.17 M | $22.70 M |
| 03/24/2022 | Q4 2021 | $0.12 | $0.26 | 0.14 | $20.93 M | $20.40 M |
| 11/12/2021 | Q3 2021 | N/A | $0.40 | N/A | $24.32 M | $30.10 M |
| 08/12/2021 | Q2 2021 | $0.22 | $0.34 | 0.12 | $20.77 M | $27.36 M |
| 05/13/2021 | Q1 2021 | $0.22 | $0.28 | 0.06 | $19.89 M | $20.02 M |
| 03/25/2021 | Q4 2020 | $0.48 | $0.46 | -0.02 | $24.99 M | $27.15 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Co-Diagnostics, Inc. Earnings: FAQ's
Co-Diagnostics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 13th, 2025 based offlast year's report dates.
In the previous quarter, Co-Diagnostics, Inc. (:CODX) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.03.
The conference call for Co-Diagnostics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Co-Diagnostics, Inc.'s latest earnings report can be read online.
Co-Diagnostics, Inc. (:CODX) has a recorded annual revenue of $3.92 M.
Co-Diagnostics, Inc. (:CODX) has a recorded net income of $-37,639,008.Co-Diagnostics, Inc. has generated $-1.24 earnings per share over the last four quarters.
Co-Diagnostics, Inc. (:CODX) has a price-to-earnings ratio of -0.41 and price/earnings-to-growth ratio is -0.03.